This is good news, not only for those with the Leber’s Congenital Amaurosis disease, but also for the entire field of gene therapy which had suffered setbacks when a a teenager named Jesse Gelsinger died of organ failure just days after receiving a gene therapy treatment at the University of Pennsylvania in 1999.
Successful gene therapy for blindness